about
Regulation of cardiovascular cellular processes by S-nitrosylationIndependent and combined influence of AGTR1 variants and aerobic exercise on oxidative stress in hypertensives.Impaired flow-induced dilation of coronary arterioles of dogs fed a low-salt diet: roles of ANG II, PKC, and NAD(P)H oxidase.Renal injury in angiotensin II+L-NAME-induced hypertensive rats is independent of elevated blood pressure.Cardiac NO signalling in the metabolic syndrome.Chronic exercise preserves renal structure and hemodynamics in spontaneously hypertensive rats.Peptides-Derived from Thai Rice Bran Improves Endothelial Function in 2K-1C Renovascular Hypertensive RatsRenoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailabilityCardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from the ONTARGET Trial ProgrammeTargeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade.Differential effects of sex steroids in young and aged female mRen2.Lewis rats: a model of estrogen and salt-sensitive hypertension.Effects of Lactobacillus plantarum TWK10-Fermented Soymilk on Deoxycorticosterone Acetate-Salt-Induced Hypertension and Associated Dementia in Rats.Combined therapy with a calcium channel blocker and an angiotensin II type 1 receptor blocker.Increased Blood Pressure Variability Prior to Chronic Kidney Disease Exacerbates Renal Dysfunction in Rats.Link between the renin-angiotensin system and insulin resistance: implications for cardiovascular disease.The effect of probiotic-fermented soy milk on enhancing the NO-mediated vascular relaxation factors.Adiponectin Attenuates Angiotensin II-Induced Vascular Smooth Muscle Cell Remodeling through Nitric Oxide and the RhoA/ROCK Pathway.Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.Tempol blunts afferent arteriolar remodeling in chronic nitric oxide-deficient hypertension without normalizing blood pressure.Divergent regulation of circulating and intrarenal renin-angiotensin systems in response to long-term blockade.Antihypertensive Effects of Roselle-Olive Combination in L-NAME-Induced Hypertensive Rats.Hypotension in NKCC1 null mice: role of the kidneys.Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model.Effects of equol on deoxycorticosterone acetate salt-induced hypertension and associated vascular dementia in rats.Rutaecarpine inhibits angiotensin II-induced proliferation in rat vascular smooth muscle cells.NO Signaling in the Cardiovascular System and Exercise.The effects of atorvastatin on oxidative stress in L-NAME-treated rats.eNOS gene delivery prevents hypertension and reduces renal failure and injury in rats with reduced renal mass.Regular exercise produced cardioprotective effects on rat's heart with hypertension induced by L-NAME administration.Increased cardiac endothelial nitric oxide synthase expression in patients taking angiotensin-converting enzyme inhibitor therapy.Association between insulin resistance and the development of cardiovascular disease
P2860
Q24300987-4EA4CEA7-F94E-4208-A20B-BD6F3B425679Q34069005-4A2E682B-F640-4374-9CB2-8314A4BB9C3AQ34357670-0D9A2DE6-F481-4C47-B77C-85EA342F179FQ34784051-CD672611-FAB4-4C67-B7B3-E246DDE9C0AAQ35204828-232312D9-C134-4A9D-A74B-846C1D242087Q35567372-FFA1F709-6D53-4572-AB61-DE4621F5F7D9Q35895079-41FC4264-F50C-473B-906C-02BE91B19C99Q36807095-D635C921-D3DB-4897-BC11-3AED09ED7CE2Q36855006-CD86DC36-2F87-4949-93D5-17602704C63FQ36863534-A2C8C0A6-18D7-4F20-9809-E07ADA177E09Q36877109-8B19DA81-F909-4805-9AD3-6EBD022C5D18Q36941740-2E12C97C-FFDA-47FF-B88D-8F55302ABF82Q37050156-265DCF1E-5403-4AF6-B746-1480108579EAQ37277486-932A6104-68F8-4F76-8AFE-FF097D928671Q38027785-1754C222-58E3-4E73-BAB0-4D7CD2985881Q39274622-B97D2728-806A-42EE-A86D-E73EA66426DDQ39930257-B33780A9-9DD8-46A7-8227-462E3B93E357Q43277441-1840B41A-2318-4AA7-9AAC-084968DDD0FBQ44550252-3E611B7D-D0AB-4A4D-A30D-A86553A0B7B3Q46565093-1AD93636-CF76-40A9-813D-3E87D7860777Q46656886-DEA1EFBA-A519-4E43-AB86-94E799E10A2CQ46701043-A975C38B-413A-4B03-9BCB-4A1E83DD8AA5Q46918335-F580AC8B-87D6-4F26-AB7C-9BD942483068Q48615252-0DA75B37-1008-4BC8-A2A7-0172E363DE42Q50899977-23F5DF7D-8015-4A43-AF8A-9288E4490C8EQ51790342-FC242947-AD5A-4114-B683-4CFAAD8EE7B1Q53090683-580B3F02-12DE-494F-B2A7-39BECADF5EDFQ53202736-16CC2581-6459-496F-AFCF-CC2253FDCA7EQ53366989-F8EBB9E3-C6C2-4955-82EC-F570A8EE3BA7Q54581677-8FA666D7-6A38-4274-B900-5E8AD669AA4CQ58782220-B00E3710-3B29-4E9C-ADC6-664AB8BB27F8
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Nitric oxide, angiotensin II, and hypertension.
@ast
Nitric oxide, angiotensin II, and hypertension.
@en
type
label
Nitric oxide, angiotensin II, and hypertension.
@ast
Nitric oxide, angiotensin II, and hypertension.
@en
prefLabel
Nitric oxide, angiotensin II, and hypertension.
@ast
Nitric oxide, angiotensin II, and hypertension.
@en
P2093
P1476
Nitric oxide, angiotensin II, and hypertension.
@en
P2093
Ivonne H Schulman
Leopoldo Raij
Ming-Sheng Zhou
P304
P356
10.1016/J.SEMNEPHROL.2004.04.008
P577
2004-07-01T00:00:00Z